IP Library Granted Patent US 12,290,282
Granted Patent B2
US 12,290,282 · App. 18/452,063 · Granted May 6, 2025

Expandable access systems and methods

Inventors: Peter M. Bonutti (Manalapan, FL); Matthew M. Cremens (Effingham, IL)
Assignee: P TECH, LLC
A61B17/3439A61B17/3498A61M25/0662A61B2017/3441A61B17/3462A61M2025/0024
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,290,282
App. No.
18/452,063
Granted
May 6, 2025
Kind
B2
Abstract

Embodiments may include an expandable access system having contracted and expanded configurations. The system and methods may include an expandable access device having a helix or wrapped shape. Embodiments may include a cannula, stent, needle, trocar, introducer, fastener, and/or any other devices disclosed herein. Embodiments may also include an expandable trocar positionable in at least a portion of the access device. A sleeve or band may be disposed over at least a portion of the access device and configured to resist radial expansion of the access device. Expansion of the trocar and/or receipt of an object may radially expand the access device between a contracted configuration and an expanded configuration.

Claims (32)

1. An expandable access system comprising:

a needle end trocar having a sharp leading end;

a cannula defining an access passage, the cannula configured to be positioned a contracted configuration around the needle end trocar;

a retaining component configured to resist radial expansion of the cannula,

wherein the needle end trocar is configured to directly penetrate through skin and into a body part,

wherein the needle end trocar is configured to be detached from the cannula and removed from the body part and the skin, and

wherein the cannula is configured to expand radially into an expanded configuration against the skin and body part to distract tissues when at least a portion of the retaining component is removed, such that the access passage created by the cannula in the expanded configuration is larger than the access passage defined by the cannula in the contracted configuration.

2. The system of claim 1 , wherein the cannula and the needle end trocar are configured to mechanically interlock when the needle end trocar is configured to penetrate through skin and into a body part and configured to unlock when the needle end trocar is detached and removed, and the cannula is expanded.

3. The system of claim 1 , wherein the access passage enables the removal of at least one of blood and body fluids from the body part.

4. The system of claim 1 , further comprising features on the external surfaces of the cannula configured to engage with at least one of the body part and the tissues.

5. The system of claim 1 , wherein the access passage enables the introduction of therapeutic substances to the body part, wherein the therapeutic substances are at least one of antibiotics, hydroxyapatite, anti-inflammatory agents, steroids, antibiotics, analgesic agents, chemotherapeutic agents, bone morphogenetic protein (BMP), demineralized bone matrix, collagen, growth promoting materials, growth factors, autogenetic bone marrow, progenitor cells, calcium sulfate, immunosuppressants, fibrin, osteoinductive materials, apatite compositions, germicides, fetal cells, adult cells, stem cells, enzymes, proteins, hormones, cell therapy substances, gene therapy substances, and combinations thereof.

6. The system of claim 1 , wherein heating the cannula with an external energy source causes the cannula to at least one of expand into the expanded configuration and contract into the contracted configuration.

7. The system of claim 1 , wherein cooling the cannula with an external energy source causes the cannula to at least one of expand into the expanded configuration and contract into the contracted configuration.

8. The system of claim 1 , wherein the cannula in the expanded configuration has a variable cross-section along the length of the access passage.

9. The system of claim 1 , wherein the access passage of the cannula in the expanded configuration is configured to connect to a fluid connection including a fluid line, wherein the fluid connection is coupled to at least one of a fluid source and a pressure source.

10. The system of claim 1 , wherein the access passage enables the introduction of at least one implant to the body part.

11. The system of claim 1 , wherein the body part is at least one of a vessel and a lumen.

12. An expandable access system comprising:

a needle end trocar having a sharp leading end;

a cannula defining an access passage, the cannula configured to be positioned in a contracted configuration around the needle end trocar;

a retaining component configured to resist radial expansion of the cannula,

wherein the needle end trocar is configured to directly penetrate through skin and into a vascular structure,

wherein the needle end trocar is configured to be detached from the cannula and removed from the vascular structure and the skin, and

wherein the cannula is configured to expand radially into an expanded configuration against the skin and vascular structure to distract tissues when at least a portion of the retaining component is removed, such that the access passage created by the cannula in the expanded configuration is larger than the access passage defined by the cannula in the contracted configuration.

13. The system of claim 12 , wherein the vascular structure is at least one of a vessel, vein, artery, and heart.

14. The system of claim 12 , wherein the access passage enables the removal of at least one of blood and body fluids from the body part.

15. The system of claim 12 , wherein the access passage enables the introduction of therapeutic substances to the vascular structure, wherein the therapeutic substances are at least one of antibiotics, hydroxyapatite, anti-inflammatory agents, steroids, antibiotics, analgesic agents, chemotherapeutic agents, bone morphogenetic protein (BMP), demineralized bone matrix, collagen, growth promoting materials, growth factors, autogenetic bone marrow, progenitor cells, calcium sulfate, immunosuppressants, fibrin, osteoinductive materials, apatite compositions, germicides, fetal cells, adult cells, stem cells, enzymes, proteins, hormones, cell therapy substances, gene therapy substances, and combinations thereof.

16. The system of claim 12 , wherein heating the cannula with an external energy source causes the cannula to at least one of expand into the expanded configuration and contract into the contracted configuration.

17. The system of claim 12 , wherein cooling the cannula with an external energy source causes the cannula to at least one of expand into the expanded configuration and contract into the contracted configuration.

18. The system of claim 12 , wherein the cannula in the expanded configuration has a variable cross-section along the length of the access passage.

19. The system of claim 12 , wherein the access passage of the cannula in the expanded configuration is configured to connect to a fluid connection including a fluid line, wherein the fluid connection is coupled to at least one of a fluid source and a pressure source.

20. The system of claim 12 , wherein the access passage enables the introduction of at least one implant into the vascular structure configured to remain in the vascular structure after removal of the cannula, wherein the at least one implant is at least one of a stent, a cardiac implant, and a vascular implant.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 2023
From: BONUTTI, PETER M.; CREMENS, MATTHEW J.
To: P TECH, LLC
Reel/Frame 064635/0536 →
Continuity (4)
Continuation 16929038 · Jul 14, 2020
Continuation 15297227 · Oct 19, 2016
Continuation 13683847 · Nov 21, 2012
Related Publication 20240058035A1 · Feb 22, 2024
References Cited (67)
US 2899959A · Ginsburg · 1958 [cited by applicant]
US 3598118A · Warren · 1971 [cited by applicant]
US 3788318A · Kim et al. · 1974 [cited by applicant]
US 4327709A · Hanson et al. · 1982 [cited by applicant]
US 4518383A · Evans · 1985 [cited by applicant]
US 4610671A · Luther · 1986 [cited by applicant]
US 4716901A · Jackson · 1988 [cited by examiner]
US 5037427A · Harada et al. · 1991 [cited by applicant]
US 5139511A · Gill et al. · 1992 [cited by applicant]
US 5158545A · Trudell et al. · 1992 [cited by applicant]
US 5158548A · Lau et al. · 1992 [cited by applicant]
US 5183464A · Dubrul et al. · 1993 [cited by applicant]
US 5257975A · Foshee · 1993 [cited by applicant]
US 5314418A · Takano et al. · 1994 [cited by applicant]
US 5431676A · Dubrul et al. · 1995 [cited by applicant]
US 5707359A · Bufallni · 1998 [cited by applicant]
US 5980530A · Wilard · 1999 [cited by applicant]
US 6019778A · Wilson et al. · 2000 [cited by applicant]
US 6162236A · Osada · 2000 [cited by applicant]
US 6190357B1 · Ferrari et al. · 2001 [cited by applicant]
US 6197014B1 · Samson · 2001 [cited by applicant]
US 6280412B1 · Pederson, Jr. · 2001 [cited by applicant]
US 6331186B1 · Wang · 2001 [cited by applicant]
US 6595946B1 · Pasqualucci · 2003 [cited by applicant]
US 6607552B1 · Hanson · 2003 [cited by applicant]
US 6673042B1 · Samson et al. · 2004 [cited by applicant]
US 7052483B2 · Wojcik · 2006 [cited by applicant]
US 7144388B2 · Crawford · 2006 [cited by applicant]
US 7306617B2 · Majercak · 2007 [cited by applicant]
US 7449011B2 · Wenchell · 2008 [cited by examiner]
US 7597688B1 · Masson · 2009 [cited by applicant]
US 7637901B2 · Lawrence et al. · 2009 [cited by applicant]
US 7799046B2 · White et al. · 2010 [cited by applicant]
US 7824392B2 · Zhou · 2010 [cited by applicant]
US 7850600B1 · Piskun · 2010 [cited by examiner]
US 7883474B1 · Mirigian et al. · 2011 [cited by applicant]
US 7896897B2 · Gresham et al. · 2011 [cited by applicant]
US 7955313B2 · Boismier · 2011 [cited by applicant]
US 7967776B2 · Von Segesser · 2011 [cited by applicant]
US 8007529B2 · Yan · 2011 [cited by applicant]
US 8070731B2 · Wenchell et al. · 2011 [cited by applicant]
US 8105288B2 · Keyser et al. · 2012 [cited by applicant]
US 9498249B2 · Bonutti · 2016 [cited by examiner]
US 10709474B2 · Bonutti · 2020 [cited by examiner]
US 20020038141A1 · Yang · 2002 [cited by applicant]
US 20030033000A1 · DiCaprio · 2003 [cited by applicant]
US 20030171716A1 · Ejlersen · 2003 [cited by applicant]
US 20040193113A1 · Gillis · 2004 [cited by examiner]
US 20040215307A1 · Mlichels et al. · 2004 [cited by applicant]
US 20040236412A1 · Brar et al. · 2004 [cited by applicant]
US 20050038408A1 · Von Segesser · 2005 [cited by applicant]
US 20050070851A1 · Thompson · 2005 [cited by applicant]
US 20050107817A1 · White · 2005 [cited by applicant]
US 20050113901A1 · Coe · 2005 [cited by applicant]
US 20060030922A1 · Dolan · 2006 [cited by applicant]
US 20060036214A1 · Mogensen et al. · 2006 [cited by applicant]
US 20060106415A1 · Gabbay · 2006 [cited by examiner]
US 20060201512A1 · Garrett et al. · 2006 [cited by applicant]
US 20070233041A1 · Gellman · 2007 [cited by applicant]
US 20080039917A1 · Cross et al. · 2008 [cited by applicant]
US 20080243162A1 · Shibata et al. · 2008 [cited by applicant]
US 20080287971A1 · Kuntz · 2008 [cited by applicant]
US 20090259143A1 · Bakhtyari-Nejad-Esfahani · 2009 [cited by applicant]
US 20100004662A1 · Ollivier · 2010 [cited by applicant]
US 20100140125A1 · Mathiasen et al. · 2010 [cited by applicant]
US 20120283518A1 · Hart · 2012 [cited by applicant]
WO 2008092782 · 2008 [cited by applicant]